Magnetic resonance angiography and vascular corrosion casting as tools in biomedical research: application to transgenic mice modeling Alzheimer's disease

Abstract In vivo imaging technologies are presently receiving considerable attention in the biomedical and pharmaceutical research areas. One of the principal imaging modalities is magnetic resonance imaging (MRI). The multiparametric nature of MRI enables anatomical, functional and even molecular information to be obtained non-invasively from intact organisms at high spatial resolution. Here we describe the use of one MRI modality, namely angiography (MRA), to non-invasively study the arterial vascular architecture of APP23 transgenic mice modeling Alzheimer's disease. Because the spatial resolution of the technique is limited, the in vivo studies are complemented by a powerful analysis of the vasculature using vascular corrosion casting. Both techniques revealed age-dependent blood flow alterations and cerebrovascular abnormalities in these mice. Our experience suggests that MRA complemented by cast analysis are important tools to describe vascular alterations and test new therapy concepts in animal models of AD. Furthermore, being non-invasive, MRA can also be applied to studies in patients suffering from this disease.

[1]  B Minnich,et al.  Lengths measurements in microvascular corrosion castings: two-dimensional versus three-dimensional morphometry. , 2006, Scanning.

[2]  O. Wiestler,et al.  Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.

[3]  Thomas G. Beach,et al.  Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Thomas Krucker,et al.  Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease , 2003, The Journal of Neuroscience.

[5]  F. Crawford,et al.  Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. , 2003, Neurological research.

[6]  M. Bock,et al.  High‐resolution three‐dimensional MR angiography of rodent tumors: Morphologic characterization of intratumoral vasculature , 2003, Journal of magnetic resonance imaging : JMRI.

[7]  C. Cotman,et al.  Atherosclerotic Lesions and Mitochondria DNA Deletions in Brain Microvessels as a Central Target for the Development of Human AD and AD‐Like Pathology in Aged Transgenic Mice , 2002, Annals of the New York Academy of Sciences.

[8]  N. Patel,et al.  Proinflammatory and Vasoactive Effects of Aβ in the Cerebrovasculature , 2002, Annals of the New York Academy of Sciences.

[9]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[10]  Marco Stampanoni,et al.  High resolution X-ray detector for synchrotron-based microtomography , 2002 .

[11]  M. Kirkitadze,et al.  Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies , 2002, Journal of neuroscience research.

[12]  Thomas Krucker,et al.  Targeted Disruption of RC3 Reveals a Calmodulin-Based Mechanism for Regulating Metaplasticity in the Hippocampus , 2002, The Journal of Neuroscience.

[13]  P. Llorca,et al.  Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  M. Brechbiel,et al.  Micro‐MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: Reference to pharmacokinetic properties of dendrimer‐based MR contrast agents , 2001, Journal of magnetic resonance imaging : JMRI.

[15]  D. Cornfield,et al.  Aβ-peptides enhance vasoconstriction in cerebral circulation , 2001 .

[16]  M. Hoehn,et al.  MR angiographic investigation of transient focal cerebral ischemia in rat , 2001, NMR in biomedicine.

[17]  G. Hellermann,et al.  Physiological levels of β-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production , 2001 .

[18]  F. Hossler,et al.  Vascular Corrosion Casting: Review of Advantages and Limitations in the Application of Some Simple Quantitative Methods , 2001, Microscopy and Microanalysis.

[19]  C. Finch,et al.  Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.

[20]  M. Staufenbiel,et al.  Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy , 2001, The Journal of Neuroscience.

[21]  M. Staufenbiel,et al.  Pathogenic Mechanisms of Alzheimer's Disease Analyzed in the APP23 Transgenic Mouse Model , 2000, Annals of the New York Academy of Sciences.

[22]  N. Beckmann,et al.  High resolution magnetic resonance angiography non‐invasively reveals mouse strain differences in the cerebrovascular anatomy in vivo , 2000, Magnetic resonance in medicine.

[23]  S. Halpain,et al.  Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Jucker,et al.  Mechanisms of Cerebrovascular Amyloid Deposition: Lessons from Mouse Models , 2000, Annals of the New York Academy of Sciences.

[25]  P. Grammas.  A damaged microcirculation contributes to neuronal cell death in Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[26]  C. Broeckhoven,et al.  Behavioral Disturbances without Amyloid Deposits in Mice Overexpressing Human Amyloid Precursor Protein with Flemish (A692G) or Dutch (E693Q) Mutation , 2000, Neurobiology of Disease.

[27]  B. Sommer,et al.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Beckmann,et al.  High-resolution magnetic resonance angiography of the mouse brain: application to murine focal cerebral ischemia models. , 1999, Journal of magnetic resonance.

[29]  R. Koeppe,et al.  Global Cerebral Blood Flow Increase Reveals Focal Hypoperfusion in Schizophrenia , 1999, Neuropsychopharmacology.

[30]  Edward W. N. Bernroider,et al.  Three‐dimensional morphometry in scanning electron microscopy: a technique for accurate dimensional and angular measurements of microstructures using stereopaired digitized images and digital image analysis , 1999, Journal of microscopy.

[31]  G. Arendash,et al.  Intravascular β-amyloid infusion increases blood pressure: implications for a vasoactive role of β-amyloid in the pathogenesis of Alzheimer's disease , 1999, Neuroscience Letters.

[32]  T. Reese,et al.  Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents , 1999, NMR in biomedicine.

[33]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[35]  M. Uchiyama,et al.  Latent cerebral artery stenoses on magnetic resonance angiography in a patient diagnosed as probable Alzheimer disease , 1998, Psychiatry and clinical neurosciences.

[36]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Thomas,et al.  beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain. , 1997, Neurological research.

[38]  D. Sparks.  Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease? , 1997, Annals of the New York Academy of Sciences.

[39]  M. Rudin,et al.  Allo- and autotransplantation of carotid artery--a new model of chronic graft vessel disease: evaluation by magnetic resonance imaging and histology. , 1997, Transplantation.

[40]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[41]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[42]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[43]  M. Mullan,et al.  β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.

[44]  L W Hedlund,et al.  Three dimensional magnetic resonance microangiography of rat neurovasculature , 1994, Magnetic resonance in medicine.

[45]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[46]  Konerding Ma.  Scanning electron microscopy of corrosion casting in medicine. , 1991 .

[47]  J. Ulrich,et al.  Alzheimer's Disease: A Description of the Structural Lesions , 1991, Brain pathology.

[48]  A. Lametschwandtner,et al.  Scanning electron microscopy of vascular corrosion casts--technique and applications: updated review. , 1990, Scanning microscopy.

[49]  E M Haacke,et al.  Optimizing blood vessel contrast in fast three‐dimensional MRI , 1990, Magnetic resonance in medicine.

[50]  H. Vinters,et al.  Stroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease , 1989, Journal of Neurology.

[51]  W. Kaiser,et al.  MR Angiography with Gradient Motion Refocusing , 1988, Journal of computer assisted tomography.

[52]  G T Gullberg,et al.  MR vascular imaging with a fast gradient refocusing pulse sequence and reformatted images from transaxial sections. , 1987, Radiology.

[53]  A. Shimakawa,et al.  Time-of-flight MR flow imaging: selective saturation recovery with gradient refocusing. , 1986, Radiology.

[54]  Arnold B. Scheibel,et al.  The Biological Substrates of Alzheimer's Disease , 1986 .

[55]  A. Haase,et al.  Rapid NMR imaging of dynamic processes using the FLASII technique , 1986, Magnetic resonance in medicine.

[56]  T Murakami,et al.  Application of the scanning electron microscope to the study of the fine distribution of the blood vessels. , 1971, Archivum histologicum Japonicum = Nihon soshikigaku kiroku.

[57]  G. Hellermann,et al.  Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. , 2001, Neurological research.

[58]  D. Cornfield,et al.  A beta-peptides enhance vasoconstriction in cerebral circulation. , 2001, American journal of physiology. Heart and circulatory physiology.

[59]  B. Sommer,et al.  TRANSGENIC ANIMAL MODELS IN THE DEVELOPMENT OF THERAPEUTIC STRATEGIES FOR ALZHEIMER’S DISEASE , 1998 .

[60]  P Rüegsegger,et al.  3D Micro-Tomographic imaging and Quantitative Morphometry for the Nondestructive Evaluation of Porous Biomaterials , 1996 .

[61]  M. Mullan,et al.  beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.

[62]  F Fazio,et al.  Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease. , 1995, Dementia.

[63]  J. C. de la Torre,et al.  Can disturbed brain microcirculation cause Alzheimer's disease? , 1993, Neurological research.

[64]  M. Konerding.  Scanning electron microscopy of corrosion casting in medicine. , 1991, Scanning microscopy.

[65]  A. Lametschwandtner,et al.  Scanning electron microscopy of vascular corrosion casts--technique and applications. , 1984, Scanning electron microscopy.

[66]  A. Miodoński,et al.  SEM BLOODVESSEL CASTS ANALYSIS , 1981 .